![Rituximab (RTX)](/upload/item/img/Rituximab-(RTX)-O099.gif)
Rituximab is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of immune system B cells. Rituximab destroys B cells and is therefore used to treat diseases which are characterized by excessive numbers of B cells, overactive B cells, or dysfunctional B cells. This includes many lymphomas, leukemias, transplant rejection, and autoimmune disorders. Rituximab destroys both normal and malignant B cells that have CD20 on their surfaces, and is therefore used to treat diseases which are characterized by having too many B cells, overactive B cells, or dysfunctional B cells. Rituximab is used to treat cancers of the white blood system such as leukemias and lymphomas, including Hodgkin's lymphoma and its lymphocyte predominant subtype. Rituximab is now being used off-label in the management of kidney transplant recipients.
Organism species: Pan-species (General)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | n/a | Complete Antigen of Rituximab (RTX) | Antigenic Transformation Customized Service Offer |
Antibodies | n/a | Monoclonal Antibody to Rituximab (RTX) | Monoclonal Antibody Customized Service Offer |
n/a | Polyclonal Antibody to Rituximab (RTX) | Polyclonal Antibody Customized Service Offer | |
Assay Kits | n/a | CLIA Kit for Rituximab (RTX) | CLIA Kit Customized Service Offer |
n/a | ELISA Kit for Rituximab (RTX) | ELISA Kit Customized Service Offer |